Novo Nordisk
NVO
#111
Rank
A$261.11 B
Marketcap
A$59.23
Share price
-1.64%
Change (1 day)
-15.75%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): A$4.29

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is A$5.74. In 2022 the company made an earnings per share (EPS) of A$3.16 an increase over its 2021 EPS that were of A$2.90.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$4.2935.91%
2022A$3.169.01%
2021A$2.9015.08%
2020A$2.5214.83%
2019A$2.19-1.68%
2018A$2.234.96%
2017A$2.1231.08%
2016A$1.62-10.33%
2015A$1.8113.91%
2014A$1.594.03%
2013A$1.53-28.81%
2012A$2.14108.9%
2011A$1.0325.59%
2010A$0.8235.01%
2009A$0.60-9.17%
2008A$0.6761.35%
2007A$0.4128.96%
2006A$0.3225.63%
2005A$0.254.17%
2004A$0.2413.55%
2003A$0.2236.87%
2002A$0.16-6.99%
2001A$0.1721.56%
2000A$0.1449.45%
1999A$0.093133.78%
1998A$0.0897412.15%
1997A$0.0800224.74%
1996A$0.06415

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.03-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.96 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.88-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.58 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA